Opportunity Overview
The New Jersey Department of Health Heart and Stroke Grant 2027, NOFA reference DOHP27HSG, is an FY2027 opportunity administered through the NJDOH Division of Health Promotion. The current FY2026-2027 NJDOH Directory of Grant Programs lists the program as open with an application due date of September 30, 2026.
Funding and Award Period
The grant-specific source record verified for this opportunity lists an estimated $225,000 in total program funding for the October 1, 2026 through September 30, 2027 grant period. Atlas does not infer a per-applicant ceiling where the controlling public materials do not state one.
Eligibility
Verified eligible applicant categories include municipal government, county government, institutions of higher education, and hospitals. Continuation applicants must demonstrate relevant history and knowledge delivering prevention programs addressing risk factors for heart disease and stroke.
Applicants must maintain required organizational compliance documentation, including a valid New Jersey Tax Clearance Certificate and, when applicable, a valid New Jersey Charities Registration Letter of Compliance.
Application and Controls
The application is administered through the NJDOH System for Administering Grants Electronically (SAGE). The application availability date is September 11, 2026. The public NJDOH directory states a September 30, 2026 due date but does not state an exact submission clock time or timezone, so Atlas does not invent one.
Program contact: Marisol Meyer, New Jersey Department of Health, 609-913-5362, marisol.meyer@doh.nj.gov.
Detailed allowable and unallowable costs, procurement and subcontract controls, match or cost share terms, required forms, and final submission mechanics must be confirmed from the current RFA before an applicant advances.
Program Purpose
The Heart and Stroke Grant supports activities intended to improve prevention and management of cardiovascular disease in New Jersey.
Program Considerations
Cardiovascular prevention and management can present clinical monitoring and examination use cases. However, the verified public materials do not establish an approved device, equipment, telehealth, or vendor-cost pathway, so any such cost should be confirmed against the controlling RFA before budgeting.
This is a current New Jersey healthcare funding opportunity with direct cardiovascular relevance, but applicant and cost eligibility controls require further RFA verification before an application is advanced.
Next Action
Applicants should retrieve and review the current RFA before advancing an application. Verify incumbent or continuation requirements where applicable, the exact submission time and timezone, allowable technology and vendor costs, match or cost share terms, required forms, procurement rules, and final SAGE submission mechanics.
Official source: NJDOH FY2026-2027 Directory of Grant Programs.